Oxford Nanopore initiates legal proceedings against Pacific Biosciences

Oxford Nanopore has initiated its first legal proceedings in Europe against Pacific Biosciences* for infringement of EP1192453, which Oxford Nanopore has an exclusive right to commercialise under a license agreement with Harvard University.

*refers to Pacific Biosciences Inc of California and Pacific Biosciences Ltd (UK).

< | >